I-SARS-CoV-2, i-Influenza A&B Antigen eDityanisiweyo yeKit-EU CE

I-COVID-19, umkhuhlane A okanye uFlu B zabelana ngeempawu ezifanayo, nto leyo eyenza kube nzima ukwahlula phakathi kosulelo lwentsholongwane emithathu.

IiMfuno

Uxilongo oluchanekileyo oluchanekileyo lubalulekile ukukhokela unyango olufanelekileyo lwe-antiviral.

Nangona besabelana ngeempawu ezifanayo, usulelo lwe-COVID-19, uMkhuhlane A kunye no-Flu B lufuna unyango olwahlukileyo lwe-antiviral.Umkhuhlane unokunyangwa nge-neuraminidase inhibitors kunye ne-COVID-19 eqatha nge-remdesivir/sotrovimab.

Isiphumo esihle kwintsholongwane enye ayithethi ukuba ukhululekile kwezinye.I-Co-infections yandisa ingozi yesifo esibi, ukulaliswa esibhedlele, ukufa ngenxa yemiphumo ye-synergistic.

Uxilongo oluchanekileyo ngovavanyo lwe-multiplex lubalulekile ukukhokela unyango olufanelekileyo lwe-antiviral, ngakumbi ngosulelo olunokubakho ngexesha lonyaka wentsholongwane yokuphefumla.

Izisombululo zethu

Macro & Micro-Test'sI-SARS-CoV-2, i-Influenza A&B Antigen eDityanisiweyo yoFundo, yahlula iFlu A, Flu B kunye ne-COVID-19 kunye nosulelo oluninzi olunokubakho ngexesha lesifo sokuphefumla;

Uvavanyo oluKhawulezayo lwezifo ezininzi zokuphefumla, kubandakanya i-SARS-CoV-2, iFlu A, kunye noFlu B ngesampulu enye;

Idityaniswe ngokupheleleyo test strip enendawo enye kuphela yesicelo kunye nesampulu enye efunekayo ukwahlula phakathi kwe-Covid-19, uMkhuhlane A kunye noMkhuhlane B;

4 amanyathelo kuphela ngokukhawuleza iziphumo kuphela kwi-15-20 min, eyenza ukuba ukukhawuleza kwezigqibo zeklinikhi.

Iintlobo ezininzi zeesampuli: I-Nasopharyngeal, i-Oropharyngeal okanye i-Nasal;

Ubushushu boGcino: 4 -30 °C;

Ishelufu Ubomi: Iinyanga ezingama-24.

Iimeko ezininzi njengezibhedlele, iikliniki, amaziko ezempilo oluntu, iikhemesti, njl.

I-SARS-CoV-2

Umkhuhlane A

UmkhuhlaneB

Uvakalelo

94.36%

94.92%

93.79%

Ukuchaza ngokuthe ngqo

99.81%

99.81%

100.00%

Ukuchaneka

98.31%

98.59%

98.73%


Ixesha lokuposa: Jan-18-2024